Results 191 to 200 of about 822,085 (315)

Choosing structure over complexity: POMDPs for emerging diseases and invasive species. [PDF]

Proc Natl Acad Sci U S A
Chades I.
europepmc   +1 more source

Mycobacterial cell division arrest and smooth‐to‐rough envelope transition using CRISPRi‐mediated genetic repression systems

FEBS Open Bio, EarlyView.
CRISPRI‐mediated gene silencing and phenotypic exploration in nontuberculous mycobacteria. In this Research Protocol, we describe approaches to control, monitor, and quantitatively assess CRISPRI‐mediated gene silencing in M. smegmatis and M. abscessus model organisms.
Vanessa Point, Wafaa Achache, Janïs Laudouze, Eliana Sepulveda Ramos, Mickaël Maziero, Céline Crauste, Stéphane Canaan, Pierre Santucci   +7 more
wiley   +1 more source

National Center for Emerging and Zoonotic Infectious Diseases accomplishments 2022

CDC\u2019s National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) works to protect people in the United States and around the world by preventing, detecting, and responding to outbreaks and emergences of infectious diseases.In 2022 ...

core  

Strategic planning of prevention and surveillance for emerging diseases and invasive species. [PDF]

Proc Natl Acad Sci U S A
Wang J, Hanley BJ, Thompson NE, Gong Y, Walsh DP, Gonzalez-Crespo C, Huang Y, Booth JG, Caudell JN, Miller LA, Schuler KL.   +10 more
europepmc   +1 more source

Viral Emerging Diseases: Challenges in Developing Vaccination Strategies. [PDF]

Front Immunol, 2020
Trovato M, Sartorius R, D'Apice L, Manco R, De Berardinis P.   +4 more
europepmc   +1 more source

Development of human monoclonal antibodies against TARM1 by yeast display

FEBS Open Bio, EarlyView.
Human monoclonal antibodies against TARM1 are generated by yeast display‐guided selection. These antibodies bind to soluble and cell‐surface forms of TARM1. Also, these antibodies exhibit agonistic activity in the NFAT‐GFP reporter assay, indicating that TARM1 signaling can be functionally modulated by antibodies and suggesting TARM1 as a potential ...
Rikio Yabe, Mayumi Saeki, Masaaki Hashiguchi, Sayaka Ono, Kazuhisa Aoki, Hidetaka Tanno   +5 more
wiley   +1 more source

Exploring Metrics of Biological Diversity to Better Predict and Respond to Emerging Diseases. [PDF]

Integr Comp Biol
Swei A, Broughton H, Crews A, Lilly M, Shaw G, Summers S.   +5 more
europepmc   +1 more source

Linguistic Pattern-Infused Dual-Channel Bidirectional Long Short-term Memory With Attention for Dengue Case Summary Generation From the Program for Monitoring Emerging Diseases-Mail Database: Algorithm Development Study. [PDF]

JMIR Public Health Surveill, 2022
Chang YC, Chiu YW, Chuang TW.
europepmc   +1 more source

Screening and epitope characterization of Nidogen‐2‐specific nanobodies

FEBS Open Bio, EarlyView.
Camel immunization and phage display were employed to generate high‐affinity VHH nanobodies against Nidogen‐2. After library construction, biopanning, ELISA screening, sequencing, and recombinant expression, selected nanobodies were purified and characterized, leading to the preliminary exploration of a nanobody‐based sandwich ELISA for specific ...
Jianchuan Wen, Qianqian Cui, Zhongyun Lan, Yingjun Wang, Shuaiying Zhao, Wenxuan Feng, Yunfeng Liu, Qiting Huang, Dongna Zhang, Jianfeng Xu   +9 more
wiley   +1 more source

Can physiological network mapping reveal pathophysiological insights into emerging diseases? Lessons from COVID-19. [PDF]

PLoS One
Ji CX, Sorouri M, Abdollahi M, Paknejad O, Mani AR.   +4 more
europepmc   +1 more source